Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Orvosi Hetilap|September 15, 2001
[Treatment of germ cell tumors at the threshold of the third millennium]L Géczi, P Biron, J P DrozOrvosi Hetilap|December 18, 1994
[Review of drugs used in the neutropenic period following cytostatic therapy and comparative study of doxycycline and ofloxacin in the treatment of patients with testicular cancer]M Baki, I Bodrogi, J Horti, et al.Anticancer Research|January 12, 2000
mdm-2 expression in human testicular germ-cell tumors and its clinical valueH Eid, E Institoris, L Géczi, et al.Journal of Cancer Research and Clinical Oncology|March 14, 1998
Do metallothioneins affect the response to treatment in testis cancers?H Eid, L Géczi, I Bodrogi, et al.Orvosi Hetilap|September 18, 1999
[The clinical value of mdm-2 (proto-oncogene) expression in testicular cancer, Correlation with tumor progression]M Bak, L Géczi, E Institioris, et al.Oncology|May 8, 2001
Three-year results of the first educational and early detection program for testicular cancer in HungaryL Géczi, F Gomez, Z Horváth, et al.Cancer|July 21, 1998
Expression of bcl-2 in testicular carcinoma: correlation with tumor progression and MDR1/PgpH Eid, M Gulyás, L Géczi, et al.Anticancer Research|August 26, 1998
Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteinsH Eid, L Géczi, A Mágori, et al.Oncology|June 8, 2006
Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emissionK Biro, L Noszek, P Prekopp, et al.Pageof 2